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Abstract: Previous studies have investigated differences in the volumes of subcortical structures
(e.g., caudate nucleus, putamen, thalamus, amygdala, and hippocampus) between individuals with
and without Tourette syndrome (TS), as well as the relationships between these volumes and tic
symptom severity. These volumes may also predict clinical outcome in Provisional Tic Disorder
(PTD), but that hypothesis has never been tested. This study aimed to examine whether the volumes
of subcortical structures measured shortly after tic onset can predict tic symptom severity at one-year
post-tic onset, when TS can first be diagnosed. We obtained T1-weighted structural MRI scans from
41 children with PTD (25 with prospective motion correction (vNavs)) whose tics had begun less
than 9 months (mean 4.04 months) prior to the first study visit (baseline). We re-examined them at
the 12-month anniversary of their first tic (follow-up), assessing tic severity using the Yale Global
Tic Severity Scale. We quantified the volumes of subcortical structures using volBrain software.
Baseline hippocampal volume was correlated with tic severity at the 12-month follow-up, with a
larger hippocampus at baseline predicting worse tic severity at follow-up. The volumes of other
subcortical structures did not significantly predict tic severity at follow-up. Hippocampal volume
may be an important marker in predicting prognosis in Provisional Tic Disorder.
Keywords: Tourette syndrome; tic disorders; Provisional Tic Disorder; hippocampus; prognosis
1. Introduction
Tic disorders are neurodevelopmental disorders defined by the presence of tics: sudden, rapid,
recurrent, non-rhythmic movements or vocalizations [1]. Tics are very common, appearing in at least 20%
of elementary school-aged children [2]. Provisional Tic Disorder (PTD) is diagnosed when tics have been
present for less than one year. While most children experience improvement in tic symptoms within the
first few months after tic onset, some children continue to have tics for more than one year, meeting
criteria for a Persistent (Chronic) Tic Disorder or Tourette’s Disorder (hereafter referred to as Tourette
syndrome, “TS”). For children with persisting tics, severity can be quite variable across individuals, with
some experiencing a significant worsening of tic symptoms that can impair quality of life [3]. Better
prognostic ability in PTD may lead to patient-specific treatment, with treatment focused on those who are
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at greater risk of an increase in tic symptoms. Identifying biomarkers of tics may be key in improving this
prognostic ability. However, studies in search of tic biomarkers have primarily compared people with TS
to a control sample, identifying significant differences in neurophysiological measures, such as brain
anatomy or function. Findings from such studies cannot disentangle whether the differences are due to
an underlying cause of tics or secondary, compensatory changes that occur with the prolonged presence
of tics. By contrast, biomarkers identified at the onset of tic symptoms are more likely to be related to the
primary cause of tics. Thus, the goal of the current study was to identify volumetric Magnetic Resonance
Imaging (MRI) biomarkers that can predict one-year tic outcome in children with recent-onset tics (i.e.,
tic duration < 9 months). No such study has been performed in PTD.
However, a large body of research has used structural MRI to measure volumes of subcortical
brain structures in TS, after tics have become chronic. These cross-sectional studies examined group
differences in subcortical volumes between people with diagnosed TS compared to controls, and have
generated conflicting results. One finding that has received substantial attention is reduced caudate
nucleus volume in TS in both children [4,5] and adults [5–7]. However, a more recent, large, multi-site
study found no significant differences in caudate volume between children with TS and age-matched
controls [8]. Volumetric findings in other subcortical structures have been discrepant as well. Some
studies reported smaller volumes in the putamen [5,9], thalamus [4,10], and hippocampus [11], while
others reported larger volumes in the putamen [11–13], thalamus [8,14,15], hippocampus [16,17],
and amygdala [16,18]. These discrepant results may be partially due to sample differences, including
comorbid conditions, medication use, and length of time with tics.
Moreover, MRI is highly susceptible to motion artifact, a highly problematic methodological
issue when studying children with a movement disorder. Most previous volumetric MRI studies in
TS excluded images with visually obvious motion contamination. Yet residual motion artifact even
after visual screening can lead to spurious results, such as smaller volume estimates in individuals
with more head movement during the scan [19,20]. Thus, it is possible that discrepant results were
influenced by motion artifact. Notably, our large, multi-site volumetric study of children with TS
started with structural MRI scans from 230 children with TS, but excluded 121 of these children due
to visible motion artifact in the image [8]. This restricted, yet still large, sample of 103 children with
TS (an additional 6 children were excluded for lack of a matched control) showed no differences in
caudate volume compared to 103 age-matched controls. Thus, advances in quality control may call
certain findings into question. Future studies must implement continually developing methods to
better account for motion, such as prospective motion correction scan sequences [21].
Even if findings were not discrepant, and differences in brain structure between TS and controls
were conclusive, it is impossible to resolve whether differences identified with cross-sectional studies
could serve as predictive biomarkers useful for prognosis or clinical care. Longitudinal designs are
necessary, as well as studying children at the onset of tic symptoms. The only longitudinal volumetric
MRI study of children with TS found that a smaller caudate nucleus in childhood predicted more
severe tics and other symptoms an average of 7.5 years later [9]. However, this hypothesis has not
been tested in children within the first year of tic onset.
We hypothesized a priori (https://osf.io/y5vxj) that a smaller caudate volume in children with
recent-onset tics (hereafter “NewTics”) would predict worse tic outcome at the one-year anniversary of
tic onset, i.e., that tics would worsen or show less improvement. We extended our investigation beyond
this one a priori hypothesis and examined whether the volume of other subcortical structures could
predict tic outcome in children with recent-onset tics. In order to reduce motion artifact, we adopted
prospective motion correction (vNavs sequences [21]) in our most recent data collection, in addition to
careful quality control of all scans (with and without vNavs sequences).
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2. Methods
2.1. Participants
The NewTics project is a longitudinal study of recent-onset tics conducted at Washington University
School of Medicine, St. Louis, Missouri, USA (www.newtics.org) [22]. Children with recent onset of tic
disorder often do not seek immediate medical attention, so even with active community recruitment,
it was necessary to enroll subjects over a period of years. Here, we report the results of structural MRI
data collected between September, 2010, and December, 2019. We enrolled children aged 5–10 years
in three different groups: (1) NewTics group: children with tic onset within 9 months of study
participation; (2) TS group: children with tics for more than one year, i.e., meeting criteria for Tourette’s
Disorder or Persistent Tic Disorder; (3) tic-free control group: children with no tics as assessed by
parent and self-reported history, clinical examination, and audiovisual observation. To increase the
sample size of the TS and tic-free control groups, we included 11 children with TS and 22 tic-free
children who had previously participated in other studies at Washington University School of Medicine.
Our starting sample included 54 participants in the NewTics group, 38 participants in the TS group,
and 41 participants in the tic-free group. After scan quality control (see Scan QC below), 41 NewTics,
34 TS, and 40 tic-free participants remained for analyses. Table 1 shows the characteristics of these
participants and Table 2 shows symptom status for the NewTics group at the baseline and 12-month
follow-up visits. The study was approved by the Washington University Human Research Protection
Office (IRB), protocol numbers 201109157 and 201707059. Each child assented and a parent (guardian)
gave informed consent. Additional MRI scan data and corresponding clinical information were shared
with informed consent from other studies, including CTS (IRB 201412136), MSCPI (IRB 201402100),
TRACK (IRB 201301004, 201808060), or NEWT (IRB 201601135).
Table 1. Characteristics of the participants in the NewTics, TS, and tic-free groups.
Variable NewTics TS Tic-Free
N 41 34 40
Sex 30 M/11 F 25 M/9 F 29 M/11 F
Age 7.87 ± 1.61 (5.41–10.81) 8.33 ± 1.55 (5.11–10.99) 8.18 ± 1.51 (5.19–10.92)
Tic duration (year) 0.34 ± 0.16 (0.07–0.73) 3.16 ± 1.67 (1.07–6.63) (n = 23) * n/a
YGTSS total tic score (TTS) 17.59 ± 6.10 (7–32) 18.59 ± 6.54 (7–30) n/a
YGTSS impairment 8.29 ± 8.56 (0–30) 11.17 ± 12.78 (0–40) (n = 30) * n/a
ADHD diagnosis 14 17 of 30 * 10 of 26 *
OCD diagnosis 3 5 of 30 * 0 of 26 *
N with brain active
medications 9 10 of 30 * 8 of 26 *
* Full clinical data were not available for some participants whose data came from other studies. TS: Tourette
syndrome; YGTSS: Yale Global Tic Severity Scale; ADHD: Attention Deficit Hyperactivity Disorder; OCD:
Obsessive-compulsive disorder; M: male; F: female.
Table 2. Characteristics of the NewTics group participants at the baseline and 12-month follow-up
session.
Variable Baseline Visit 12-Month Follow-Up
N 41 41
Tic duration (days) 123.07 ± 58.52 (25–268) 371.71 ± 11.13 (355–409)
YGTSS total tic score (TTS) 17.59 ± 6.10 (7–32) 13.78 ± 7.60 (0–37)
YGTSS impairment 8.29 ± 8.56 (0–30) 4.63 ± 6.84 (0–20)
DCI 33.24 ± 14.36 (12–80) 43.41 ± 15.85 (13–79)
PUTS 13.66 ± 5.39 (9–31) (n = 38)* 15.32 ± 5.65 (9–30)
ADHD rating scale (ARS) 13.41 ± 11.81 (0–40) 15.05 ± 11.92 (0–41)
ADHD diagnosis 14 17
CY-BOCS 3.95 ± 6.45 (0–26) 6.93 ± 8.62 (0–26)
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Table 2. Cont.
Variable Baseline Visit 12-Month Follow-Up
OCD diagnosis 3 9
SRS 48.83 ± 10.01 (35–78) n/a
* PUTS scores were not obtained from 3 young children at baseline visit because of difficulty in reporting these
internal phenomena. DCI: Diagnostic Confidence Index; PUTS: Premonitory Urge for Tics Scale; CY-BOCS: Child
Yale-Brown Obsessive Compulsive Scale; SRS: Social Responsiveness Scale.
2.2. Procedure
This study consisted of baseline and 12-month follow-up study visits. The baseline visit consisted
of neuropsychological tests and clinical examination on one day (the full list of assessments has been
reported in our previous work [3]) and an MRI scan visit (functional and structural MRI) within one
week of the baseline visit. Clinical examination was repeated at a follow-up session 12-months after
the best estimate date of the first definite tic. All participants who completed the study by December
2019 were included in the current report.
2.3. MRI Acquisition
To minimize scan-day discomfort and head movement, participants entered a mock scanner on the
day of their clinical examination. On the MRI day, scans lasted approximately one hour to collect T1-
and T2-weighted structural images, resting-state functional MRI, and pseudo-continuous arterial spin
labeling (pCASL) images. Scan quality was checked immediately after the acquisition, and sequences
were repeated if necessary. In the current study, high-resolution T1-weighted magnetization prepared
rapid gradient echo (MPRAGE) images covering the whole brain were analyzed. Different scanners
and sequences were used over the 9 years of data acquisition (Cohort 1: Siemens TRIO 3T MRI scanner,
176 slices, FOV = 224 × 256, 1 mm isotropic voxels, TR = 2200 ms, TE = 2.34 ms, TI = 1000 ms, and flip
angle = 7 degrees; Cohort 2: Siemens Prisma 3T MRI scanner, 196 slices, FOV = 240 × 256, 0.8 mm
isotropic voxels, TR = 2400 ms, TE = 2.22 ms, TI = 1000 ms, and flip angle = 8 degrees; Cohort 3:
Siemens Prisma 3T scanner, 196 slices, FOV = 256 × 256, 1 mm isotropic voxels, TR = 2500 ms, TE =
2.9 ms, TI = 1070 ms, and flip angle = 8 degrees). Importantly, 25 NewTics, 27 TS, and 19 tic-free
control participants were scanned with a prospective motion correction sequence (vNavs [23]; Cohort
3). We also included T1-weighted MPRAGE images from 11 children with TS and 22 children without
tics (including 11 participants scanned with a vNavs sequence) from other studies. Detailed scan
parameters are shown in Appendix A. If the participant had more than one T1 scan, the scan with the
better QC rating was used for the analysis.
2.4. Scan QC
In order to assess scan quality, we extracted MRIQC (MRI Quality Control) [24] from each T1 scan.
Among 64 image quality metrics of MRIQC, we found that the average signal-to-noise ratio (SNR)
of gray matter, white matter, and cerebrospinal fluid (CSF) (hereafter “SNR (total)”) calculated using
the within-tissue variance was highly correlated with subjective rating by visual inspection following
standardized criteria [25]. We excluded T1 scans with scan rating C3 (fail) or SNR total below 7.5 from
the further analysis (see Appendix B). Thus, 13 NewTics, 4TS, and 2 tic-free participants were excluded.
2.5. Analysis
We used a fully automatic segmentation tool, volBrain [26], which segments and quantifies the
volumes of subcortical structures including the putamen, caudate, pallidum, thalamus, hippocampus,
amygdala, and nucleus accumbens. volBrain showed superior accuracy in segmenting all seven
subcortical structures [26] compared to other publicly available software packages, FreeSurfer [27] and
FSL-FIRST [28]. Although the hippocampus is known to be difficult to segment [29], volBrain achieved
high dice similarity indices in comparison to manual segmentation in segmenting the hippocampus [30].
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VolBrain also estimates total intracranial volume (ICV). We adopted the residual approach [31]
to control for interindividual head size differences (see Appendix C). As we did not hypothesize
asymmetry to be of interest, we summed left and right hemisphere volumes for each structure. Total
(left + right) regional volumes adjusted for ICV were the dependent variables. (An exploratory
analysis of each left and right subcortical structure appears in Appendix D). We conducted multiple
regression analyses within the NewTics participants to test whether subcortical structure volume at
the baseline visit could predict tic severity at the follow-up visit. Baseline total tic score from the
Yale Global Tic Severity Scale (YGTSS), age, sex, attention-deficit/hyperactivity disorder (ADHD)
diagnosis, obsessive–compulsive disorder (OCD) diagnosis, and scanner were included as covariates,
but insignificant terms were eliminated via backward stepwise regression. Group comparisons were
conducted using one-way ANOVA. We also conducted independent t-tests specifically comparing
NewTics vs. tic-free and TS vs. tic-free. As we did not correct for multiple comparisons, we added
Bayesian hypothesis testing with the Bayesian information criterion (BIC) method. BF10 over 3 was
considered as positive [32]/substantial [33] evidence (strong evidence if BF10 > 10) [34]. We used JASP
(JASP Team. JASP Version 0.9, https://jasp-stats.org/) for Bayesian hypothesis testing and SPSS for all
other statistical analyses.
3. Results
3.1. Mean Clinical Change
Consistent with our previous report on 20 overlapping participants [3], NewTics participants’ tic
symptoms improved on average between the baseline and follow-up visits. The mean YGTSS total tic
score decreased by approximately 22% (Table 2).
3.2. Predictors of Change in the NewTics Group
Baseline hippocampal volume, but no other structure volumes, significantly predicted total tic
score at the 12-month follow-up visit, after controlling for the baseline tic symptoms (R2 = 0.492, F(1,38)
= 18.38, p < 0.001; adjusted R2 = 0.465) (Figure 1, first row). The estimated Bayes factor BF10 was
16.88, indicating strong evidence in favor of adding hippocampal volume to the null model with
baseline tic symptoms alone. Stepwise regression analysis was conducted to test whether age, sex,
handedness, comorbid ADHD diagnosis, OCD diagnosis or scanner significantly improved the model,
but none of these factors were selected. The final model is shown in Table 3. This result was not due
to an association already present at baseline. Cross-sectional analyses to examine the relationship
between the volumes of subcortical structures and the total tic score within the baseline session
revealed no significant association in any subcortical structure volumes (p ≥ 0.25; Figure 1, second
row). An exploratory analysis examining hippocampal subfields using the volBrain HIPS pipeline [35]
showed similar results for baseline CA1 volume and for combined CA2 + CA3 volume (Appendix E).
A similar post-hoc analysis found that either left or right hippocampal volume at baseline significantly
predicted follow-up total tic score (Appendix D).
Table 3. Stepwise regression analysis for prediction of tic severity at 12-month visit based on
hippocampal volume at baseline visit and other baseline clinical variables.
Variable B SEB β p
Y = Total Tic Score at 12-Month Follow-up
Hippocampus volume (Adjusted) 5.311 1.627 0.381 0.002
Total tic score at baseline session 0.676 0.145 0.542 <0.001
Intercept −38.02 12.197 0.003
B: unstandardized coefficients; SE: standard error; β: standardized coefficients.
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Figure 1. Volumes of subcortical structures adjusted for intracranial volume (ICV) and prognosis
analysis (top row), cross-sectional analysis (middle row), and group comparison analysis (bottom row).
TTS: total tic score; NT: NewTics; TS: Tourette syndrome; TF: Tic-free.
3.3. Group Comparisons
Figure 1 (bottom row) shows putamen, caudate, nucleus accumbens, globus pallidus, amygdala,
thalamus, and hippocampus volumes for each group. One-way ANOVAs revealed no significant
main effects of the group in any subcortical structure (p ≥ 0.113). As we specifically hypothesized that
children with tics (NewTics group and TS group) would differ from tic-free children (H1), we compared
the NewTics and TS groups to the tic-free group separately using independent t-tests. Hippocampal
volume differed between the NewTics and tic-free control groups (t(79)= 2.022, p= 0.047). The estimated
Bayes factor BF10 was 1.40, indicating weak evidence in favor of the alternative hypothesis (H1). There
was no significant difference between NewTics and tic-free in other subcortical structures (minimum
p = 0.122) or between TS and tic-free participants in any subcortical structures (minimum p = 0.116).
3.4. Subgroup Analysis
We conducted a subgroup analysis with the participants whose T1 scans were collected with
prospective motion correction (vNavs) sequences. We included the participants from our own NewTics
study only, as we carefully screened our tic-free controls for tics using structured interviews, direct
examination, and video monitoring of the child sitting alone. The main results with hippocampal
volume were still present. The analysis within the NewTics group showed that hippocampal volume
predicted the total tic score at the 12-month follow-up visit, after controlling for the baseline tic
symptoms (R2 = 0.618, F(1,22) = 17.8, p < 0.001; adjusted R2 = 0.583; see Figure 2, lower figures).
We found no significant association between the hippocampal volume and the total tic score within
the baseline session (r = 0.128; p = 0.542; see Figure 2, lower figures). One-way ANOVA revealed a
significant main effect of group for hippocampal volume (p = 0.018); see Appendix F); post-hoc tests
showed greater hippocampal volume in each patient group compared to controls (NewTics vs. tic-free:
t(42) = 2.66, p = 0.011; TS vs. tic-free: t(40) = 2.23, p = 0.027, uncorrected). The subgroup analyses for
other subcortical structures are shown in Appendix F.
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Figure 2. A graphical representation of the study design and a summary of the results. The upper
figures show the results of the entire set of participants (n = 41). The lower figures represent the
subgroup analysis consisting of the scans collected with vNavs (n = 25). YGTSS: Yale Global Tic Severity
Scale; MRI: Magnetic Resonance Imaging; TS: Tourette syndrome.
4. Discussion
The goal of the current study was to investigate whether the volume of subcortical structures in
children with recent-onset tics predicted tic outcome at the one-year anniversary of tic onset, when
Tourette’s Disorder or Persistent Tic Disorder can first be diagnosed. The study design and a summary
of the results are shown in Figure 2. We found that hippocampal volume measured within months of
tic onset predicted one-year tic outcome, such that children with a larger hippocampus showed worse
tic outcome (less improvement). Volumes of other subcortical structures did not significantly predict
tic outcome. We also examined whether the volumes of any subcortical structures differed between
NewTics, TS, and tic-free groups. While hippocampal volume differed between NewTics and controls,
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it was near the threshold of statistical significance. No significant difference was found in any other
subcortical structures.
Our a priori hypothesis regarding caudate volume was not supported. Smaller caudate volumes
in children and adults with TS have been repeatedly reported (reviewed in Greene et al. [36]), and a
longitudinal study showed that smaller caudate volume in children with TS predicted worse tic
outcome in young adulthood [9]. The different patterns of prognosis might be due to the different phase
of illness, or different periods of follow-up. While we studied the prognosis of children presenting
within a few months of tic onset, measured at one year, Bloch et al. [9] examined subjects at least a year
after tic onset, with a follow-up mean of 7.5 years later.
MR images acquired during even small head motion can lead to artifactually smaller
volumes [19,20], raising concerns about studies that did not specify how carefully they controlled scan
quality. We adopted a prospective motion correction sequence (vNavs [23]) to reduce the impact of
head motion, and also excluded the scan images with low SNR from the analysis. Within this carefully
controlled dataset, we found no significant group difference in caudate volume or its association
with tic symptoms. Thus, previous findings of smaller caudate volume might be partially due to the
individuals with tics moving more inside the MRI scanner. Alternatively, the lack of significance in the
current study may reflect type II error, but one of the two largest studies similarly found no significant
reduction in caudate volume in children with TS [8].
In the current study, the significant association between baseline volumes and tic symptom severity
at follow-up was specific to the hippocampus even when comorbidities were statistically controlled.
Analysis of left and right hemisphere separately revealed the same pattern of results. Hippocampal
enlargement in children with TS has been reported previously [16]. Hippocampal volume quantified at
the baseline visit was not associated with the tic symptom severity at the baseline visit. Rather, volume
was correlated with tic symptom severity at the 12-month visit, suggesting that hippocampal volume
may be related to the persistence of tic symptoms, but not the initial acquisition of tics. This finding
is consistent with the idea that tics are thought to result from aberrant habit learning [37]. Both tics
and habits are inflexible, repetitive behaviors that are acquired over a period of time. Given these
similarities, a behavioral study using a motor learning and memory task reported a negative correlation
between the rate of forgetting (unlearning) and motor tic severity [38]. Children and adolescents with
severe tics showed evidence of enhanced motor memory, in that they took longer to unlearn previously
learned motor patterns of behavior. The hippocampus plays a role in memory consolidation not just
in the cognitive domain but also in the motor domain [39]. Together with the previous behavioral
finding, our results suggest that tics, once they develop, may be more likely to persist in children with
a larger hippocampus.
The apparent lack of a significant group difference between the TS and tic-free groups is complicated.
If the hippocampus is related to the main cause of tic symptom persistence, then greater hippocampus
volume would be expected in the TS group compared to tic-free controls. This lack of significant group
difference may indicate that the hippocampus plays a critical role in initial tic symptom persistence
up to approximately a year after tic onset, but thereafter the relationship between the hippocampal
volumes and tic symptoms may be more complex. For example, ADHD, OCD [40–42], and anxiety
disorder [43]—all of which frequently co-occur with tic disorders—have been associated with reduced
hippocampal volume. However, in the current study, these clinical subgroups (among subjects
whose comorbid symptom records were available) did not differ in terms of hippocampal volume.
Comorbidity and age may also affect the relationship between hippocampal volume and tics. Although
Peterson et al. found larger hippocampal volume in children with TS, some subregions became smaller
compared to controls by adulthood [16]. Further, reduced hippocampal volumes in TS have been
reported in adolescents [44] and in adults with comorbid OCD [17]. On the other hand, the subset of
participants whose data were collected using the prospective motion correction MR sequence, and with
tics carefully screened by a semi-standardized diagnostic interview (K-SADS), direct examination,
and video recording of the child sitting alone, revealed increased hippocampal volumes in the NewTics
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and TS groups compared to the tic-free group (Supplementary Table S1). Further studies are needed to
determine whether additional data collected with this improved methodology confirm this potential
group difference. Prospective motion correction is advantageous because it can acquire the scan data
with adequate quality even in those participants with some head motion, while scan quality control
after acquisition may bias the sample by excluding the participants with more severe tic symptoms.
A recent genetics study by Mufford et al. examined the genetic variation that increases risks
for TS and its influence on the volume of specific subcortical brain structures [45]. One of their
analyses revealed evidence of pleiotropy between TS risk variants and variants associated with greater
hippocampal volume. This result is in line with our finding that a larger volume of the hippocampus
was associated with worse tic outcomes.
One limitation of the current study is that we collected MRI scans using different scanning
sequences over 9 years of recruiting. A retrospective study estimated the typical delay from the onset of
tics to diagnosis as 10 years [46]. This result highlights the difficulty in recruiting the PTD population.
The NewTics group’s total sample of 54 participants includes 29 participants who were recruited in
the first 6 years while MRI methods improved. Since receiving R01 funding for the NewTics study,
allowing more vigorous recruiting including local advertisement, and obtaining access to the vNavs
prospective motion correction method, we have used identical scan parameters for the most recent
25 participants. Importantly, all of the 25 participants with vNavs scans passed scan QC while 13 of
the first 29 participants failed scan QC. This suggests that the vNavs sample may include less selection
bias for tic symptom severity, as the vNavs sequence allows collection of adequate quality MRI scans
even from participants with greater head motion. To prevent a possible influence of varying scan
parameters on the results, we conducted a subgroup analysis limited to the most recent 25 participants,
with the vNavs sequence, and found the same prognostic value of hippocampal volume. The vNavs
scan subgroup analysis comparing the NewTics group to tic-free controls also revealed a significant
group difference in hippocampal volume that was not evident in the entire sample analysis.
In summary, our results suggest that hippocampus volume may be a critical biomarker predicting
tic symptom persistence in children with Provisional Tic Disorder. Further studies with longer follow-up
are required to understand more completely the longitudinal relationship between hippocampal volume
and tic symptoms.
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Appendix A. Structural MRI Collection Specifications
Table A1. Structural MRI collection specifications.
vNav
Category




MPRAGE; tfl3d1_ns; Frames 176; FOV 224×256 Voxels; Vox.








MPRAGE; *tfl3d1_16ns; Frames 196; FOV 240×256 Voxels;






MPRAGE; tfl3d1_16ns; Frames 196; FOV 256×256 Voxels;





non-vNav CTS SiemensTrio 3T
MPRAGE; *tfl3d1_ns; Frames 256; FOV 256×256 Voxels;
Vox. Res. 1.0 1.0 1.0; TR 2400; TE 3.08; TI 1000; flip angle 8 - 7 4
non-vNav JCA SiemensTrio 3T
MPRAGE; *tfl3d1_ns; Frames 176; FOV 256×256 Voxels;
Vox. Res. 1.0 1.0 1.0; TR 2400; TE 3.08; TI 1000; flip angle 8 - 4 -
non-vNav TRACK SiemensTrio 3T
MPRAGE; *tfl3d1_ns; Frames 192; FOV 256×256 Voxels;
Vox. Res. 1.0 1.0 1.0; TR 2400; TE 3.16; TI 1000; flip angle 8 - - 4
vNav NEWT SiemensPrisma 3T
MPRAGE; tfl3d1_16ns; Frames 192; FOV 256×256 Voxels;
Vox. Res. 1.0 1.0 1.0; TR 2500; TE 2.9; TI 1070; flip angle 8 - - 8
vNav MSCPI SiemensPrisma 3T
MPRAGE; tfl3d1_16ns; Frames 192; FOV 256×256 Voxels;
Vox. Res. 1.0 1.0 1.0; TR 2500; TE 2.9; TI 1070; flip angle 8 - - 3
non-vNav TR SiemensTrio 3T
MPRAGE; *tfl3d1_ns; Frames 176; FOV 180×180 Voxels;
Vox. Res. 1.0 1.0 1.0; TR 2400; TE 3.28; TI 1000; flip angle 8 - -
1 (1 QC
fail)
non-vNav TR SiemensTrio 3T
MPRAGE; *tfl3d1_ns; Frames 176; FOV 256×256 Voxels;
Vox. Res. 1.0 1.0 1.0; TR 2400; TE 3.12; TI 1000; flip angle 8 - - 1
non-vNav TR SiemensTrio 3T
MPRAGE; *tfl3d1_ns; Frames 174; FOV 256×256 Voxels;
Vox. Res. 1.0 1.0 1.0; TR 2400; TE 3.08; TI 1000; flip angle 8 - - 1
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Appendix B. Scan Quality Control
All scans were rated from 1 to 3, with 1 being best and 3 being worst (decimals were allowed),
using the four criteria suggested previously [25]: (1) image sharpness, (2) ringing, (3) subcortical
structure contrast-to-noise ratio (CNR), and (4) GM and WM CNR, and then averaged these four
ratings. The rater was blinded to the participants’ characteristics. We excluded two NewTics and
four TS participants whose scan rating was 3 (fail). Correlation analysis revealed that SNR (total) was
highly correlated with the averaged scan rating (Figure below). We found that SNR (total) was higher
for the scans with vNavs sequence compared to the scans without prospective motion correction, even
when the scans were rated similarly by visual inspection. The minimum SNR of the vNavs scans,
which got an average rating of 1 (pass) or 2 (check), was approximately 7.5, so we used this criterion to
quality control all scans, acquired with or without the vNavs sequence. This allowed us to include the
non-vNavs scans when they were objectively of equal quality as the vNavs scans. In total, 11 NewTics
and 1 tic-free participants were excluded due to low SNR.
Figure A1. SNR total of MRIQC. (a) The relationship between scan rating with visual inspection and
SNR (total) of T1 scans. Black circles indicate T1 scans with vNavs sequence, and white circles indicate
T1 scans with non-vNavs sequences. The histogram of SNR total of T1 scans with vNavs sequence (b)
and T1 scans with non-vNavs sequences (c). The vertical lines in (b) and (c) indicate the cutoff criterion
for scan quality control. See text in Appendix B. Scan Quality Control.
Appendix C. Intracranial Volume Adjustment
The residual approach [31] was adopted to control for interindividual head size differences. As we
did not hypothesize asymmetry to be of interest, we summed left and right hemisphere volumes for
each structure. A linear regression model was fitted between the total (left+ right) volume of subcortical
structure and intracranial volume (ICV) to predict ICV-adjusted volumes. Adjusted volumes were
obtained as the sum of the residuals from the regression model and the mean volume. Total (left +
right) regional volumes adjusted for ICV were the dependent variables.
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Figure A2. Relationship between the total (left + right) subcortical structure volumes and ICV. See text
in Appendix C. Intracranial volume adjustment.
Appendix D. Tic Severity Prognosis by Volumes of Left and Right Subcortical Structures
Baseline left and right hippocampal volume, but no other structure volumes, significantly
predicted total tic score at the 12-month follow-up visit, after controlling for baseline tic symptoms (left
hippocampus: R2 = 0.465, F(1,38) = 16.5, p < 0.001; adjusted R2 = 0.437; Right: R2 = 0.491, F(1,38) =
18.3, p < 0.001; adjusted R2 = 0.464).
Figure A3. Tic severity prognosis by volumes of left subcortical structures.
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Figure A4. Tic severity prognosis by volumes of right subcortical structures.
Appendix E. Hippocampal Subfield Analyses
As the volume of the hippocampus significantly predicted one-year tic outcome, we conducted
an exploratory analysis to test whether a specific hippocampal subfield predicted tic outcome using
volBrain HIPS pipeline [35]. The baseline CA1 volume (R2 = 0.622, F(2,57) = 46.85, p < 0.001; adjusted
R2 = 0.608) and combined CA2 + CA3 volume, (R2 = 617, F(2,57) = 45.84, p < 0.001; adjusted R2 = 0.603)
predicted 12-month total tic score, controlling for total tic score at the baseline visit such that participants
with larger CA1 volume or CA2+CA3 combined volume at the baseline visit showed less improvement
(or worsening) of tic severity.
 
Figure A5. Tic severity prognosis by volumes of hippocampal subfields.
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Appendix F. Group Comparison within the Selected Subsample
We conducted a subgroup analysis with the selected sample whose T1 scans were collected with
prospective motion correction (vNavs sequence). One-way ANOVA revealed a significant main effect
of group for hippocampal volume (p = 0.018). Post-hoc analysis revealed that both the NewTics
group (mean=7.54, SD = 0.56, t(42) = 2.66, p = 0.011) and TS group (mean = 7.47, SD = 0.53, t(40) =
2.30, p = 0.027) had larger hippocampal volume than did the tic-free group (mean = 7.05, SD = 0.64).
Volumes did not differ significantly in any other subcortical region (p ≥ 0.099).
 
Figure A6. Group comparison within the selected subsample.
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